Compositions containing alpha2-adrenergic agonist components

Details for Australian Patent Application No. 2011250793 (hide)

Owner Allergan, Inc.

Inventors Olejnik, Orest; Graham, Richard; Bakhit, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2011250793

Parent 2005280259

Filing date 15 November 2011

Wipo publication date 8 December 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

1 December 2011 Complete Application Filed

8 December 2011 Application Open to Public Inspection

  Published as AU-A-2011250793

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011250794-User-driven media system in a computer network

2011250792-System and method for dispatching by exception